Home Alexion Receives Notification of PDUFA Date Extension for Kanuma ...
 

Keywords :   


Alexion Receives Notification of PDUFA Date Extension for Kanuma ...

2015-09-04 23:15:02| Biotech - Topix.net

Alexion Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has extended the Prescription Drug User Fee Act date for its Priority Review of the Company's Biologics License Application for Kanuma a , an investigational enzyme replacement therapy for the treatment of lysosomal acid lipase deficiency . The previously disclosed September 8, 2015 PDUFA date has been extended by the standard extension period of three months.

Tags: date extension notification receives

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.114 ver. 6
23.11120
23.11 3rd tour DOUBLE STAR Blu-ray
23.11PSA8_
23.11/nd
23.11
23.11 #49
23.115in1UP
More »